Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OCRELIZUMAB vs OFLOXACIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OCRELIZUMAB vs OFLOXACIN: Safety Overview

Metric OCRELIZUMAB OFLOXACIN
Total FAERS Reports 56,186 3,062
Deaths Reported 1,406 198
Death Rate 2.5% 6.5%
Hospitalizations 10,364 1,257
Average Patient Age 47.2 yrs 58.0 yrs
% Female Patients 72.5% 53.5%
FDA Approval Date N/A Apr 12, 2024
Manufacturer Genentech, Inc. Cadila Pharmaceuticals Limited
Route INTRAVENOUS ORAL
Marketing Status Prescription Discontinued